Keywords: پاسخ ویروسی بالقوه; Competing risk; Direct-acting antivirals; Hepatitis C; Hepatocellular carcinoma; Markov model; Survival benefit; Sustained virological response;
مقالات ISI پاسخ ویروسی بالقوه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پاسخ ویروسی بالقوه; ANRS; (France REcherche Nord & sud Sida-vih Hépatites); HCV; hepatitis C virus; RNA; ribonucleic Acid; DAA; direct-acting antivirals; HCC; hepatocellular carcinoma; SVR; sustained virological response; RR; relative risk; INF; interferon; US; ultra-sound;
Keywords: پاسخ ویروسی بالقوه; AMPK; 5â²-adenosine monophosphate-activated protein kinase; BMI; body mass index; CHB; chronic hepatitis B; CHC; chronic hepatitis C; ChREBP; carbohydrate response element binding protein; Fox; forkhead box protein; HCC; hepatocellular carcinoma; HSCs;
Keywords: پاسخ ویروسی بالقوه; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IL; Interleukin; SNP; single nucleotide polymorphism; SVR; sustained virological response; TNF; tumour necrosis factor; Inflammation; Cytokines; Polymorphisms; Liver cancer;
Keywords: پاسخ ویروسی بالقوه; Hepatitis C; Insulin resistance; Sustained virological response
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
Keywords: پاسخ ویروسی بالقوه; Sofosbuvir; Daclatasvir; Simeprevir; DAA; Sustained virological response;
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: پاسخ ویروسی بالقوه; Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Keywords: پاسخ ویروسی بالقوه; HCV; Glecaprevir; Pibrentasvir; Sofosbuvir; NS5A inhibitor resistance associated variant; P32 deletion; Human hepatocyte chimeric mouse; ASV; asunaprevir; DAAs; Direct-acting antivirals; DCV; daclatasvir; GLE; glecaprevir; HCV; hepatitis C virus; LDV; led
Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response
Keywords: پاسخ ویروسی بالقوه; Pegylated interferon-α and ribavirin therapy; Left ventricular diastolic dysfunction; Chronic hepatitis C; Sustained virological response;
Correlation of CD81 and SCARB1 polymorphisms on virological responses in Iranian patients with chronic hepatitis C virus genotype 1
Keywords: پاسخ ویروسی بالقوه; Cluster of differentiation 81; Scavenger receptor class B member 1; Rapid virological response; Complete early virological response; Sustained virological response;
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
Keywords: پاسخ ویروسی بالقوه; UPLC-MS/MS; ultra performance liquid chromatograpy; LOD; limit of detection; LOQ; limit of quantification; HCV; hepatitis C virus; NS5A/5B; non-structural 5A/5B; SVR; sustained virological response; Sofosbuvir; GS-331007; Daclatasvir; DAA; HCV; Therapeu
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
Keywords: پاسخ ویروسی بالقوه; CLDN1; claudin 1, a receptor for HCV entry; Core; HCV core protein; DAA; direct antiviral agent; E1; HCV envelope protein 1; E2; HCV envelope protein 2; HCV; hepatitis C virus; HCV-1, HCV2, ⦠HCV-6; HCV genotype 1, 2 â¦6; MELD; Model for End-Stage Live
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
Keywords: پاسخ ویروسی بالقوه; CDC; Centers for Disease Control and Prevention; CLIA; chemoluminescent immunoassay; DAA; direct acting antivirals; EIA; enzyme immunoassay; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PBC; primary biliary cho
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India
Keywords: پاسخ ویروسی بالقوه; DAA; Direct Acting Antiviral; DCV; Daclatasvir; EASL; European Association of Study of the Liver (EASL); ETR; End of Treatment Response; HBV; Hepatitis B; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HIV; Human Immunedeficiency Virus; ITT; inten
Circulating miRNAs in nontumoral liver diseases
Keywords: پاسخ ویروسی بالقوه; Ago; Argonaute; AFP; α-fetoprotein; AH; alcoholic hepatitis; AIH; autoimmune hepatitis; ALD; alcoholic liver disease; ALI; acute liver injury; ALT; alanine aminotransferase; AMA; antimitochondrial antibody; AP; alkaline phosphatase; APAP; acetaminophen;
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports
Keywords: پاسخ ویروسی بالقوه; Hepatitis C virus (HCV); hemodialysis; cirrhosis; advanced liver fibrosis; sustained virological response; decreased kidney function; end-stage renal disease (ESRD); direct-acting antivirals; paritaprevir; ritonavir; ombitasvir; dasabuvir; ribavirin; HCV
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Keywords: پاسخ ویروسی بالقوه; Cirrhosis; Direct-acting antivirals; Hepatitis C virus genotype 3; Interferon-free regimens; Sustained virological response; Viral kinetics;
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevirâ±âribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
Keywords: پاسخ ویروسی بالقوه; Sofosbuvir; Simeprevir; HIV/HCV co-infection; Sustained virological response; SVR;
Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major
Keywords: پاسخ ویروسی بالقوه; PRC; packed red blood cells; HIV; human immunodeficiency virus; DAAs; direct acting antivirals; SVR; sustained virological response; RNA; ribonucleic acid; VAS; visual analogue scale; RVR; rapid virological response; EBR; elbasvir; GZR; grazoprevir; SD; s
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
Keywords: پاسخ ویروسی بالقوه; Chronic hepatitis C; DAA treatment; Immune response; miRNA-122; HCV; hepatitis C virus; IP-10; interferon gamma-induced protein; CHC; chronic hepatitis C; DAAs; direct acting antivirals; SVR; sustained virological response; miR-122; microRNA-122; RAS; res
Impact of hepatitis B vaccination on HBsAg kinetics, interferon-inducible protein 10 level and recurrence of viremia
Keywords: پاسخ ویروسی بالقوه; CccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; ECLIA; Electrochemiluminescence immunoassay; ELISA; Enzyme-linked immunosorbent assay; HBsAg; HBV surface antigen; HCC; hepatocellular carcinoma; HOMA-IR; Homeostatic model assessment for i
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Keywords: پاسخ ویروسی بالقوه; Hepatocellular carcinoma (HCC); Hepatitis C; Hepatic decompensation; Recurrences; Sustained virological response; Overall survival; Prognosis; Survival rate; Antiviral agents; Liver cirrhosis; Carcinoma, hepatocellular;
Hepatitis C-related cirrhosis. Current status
Keywords: پاسخ ویروسی بالقوه; Chronic hepatitis C; Liver cirrhosis; Direct-acting antivirals; Sustained virological response; Liver transplantation; Hepatitis crónica C; Cirrosis hepática; Antivirales de acción directa; Respuesta viral sostenida; Trasplante hepático;
Cirrosis por hepatitis C. Estado actual
Keywords: پاسخ ویروسی بالقوه; Hepatitis crónica C; Cirrosis hepática; Antivirales de acción directa; Respuesta viral sostenida; Trasplante hepático; Chronic hepatitis C; Liver cirrhosis; Direct-acting antivirals; Sustained virological response; Liver transplantation;
Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort
Keywords: پاسخ ویروسی بالقوه; HIV/HCV co-infection; All-oral DAA; Sustained virological response;
Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning
Keywords: پاسخ ویروسی بالقوه; BN; Bayesian network; COMET; context-based modeling for expeditious typing; DAA; direct acting antiviral; dN/dS; ratio of non-synonymous and synonymous substitutions; DNA; deoxyribonucleic acid; e.g.; exempli gratia (for example); ePI; PI-exposure; FEL; f
Impact of genetic polymorphisms of four cytokine genes on treatment induced viral clearance in HCV infected Egyptian patients
Keywords: پاسخ ویروسی بالقوه; Hepatitis C virus; Pegylated-interferon; Ribavirin; Sustained virological response; IL-10; TNF-α; IFN-γ; TGF-β;
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; CHC; chronic hepatitis C; HCC; hepatocellular carcinoma; LT; liver transplantation; PEG-IFN; pegylated interferon; RBV; ribavirin; SVR; sustained virological response; ANRS; France REcherche Nord & sud Sida-HIV Hépatites-FRENSH; V
Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture
Keywords: پاسخ ویروسی بالقوه; Hepatitis C virus; Carbosilane dendrimer; Antiviral; Nanotechnology; Virucidal; HCV; hepatitis C virus; DAA; direct-acting antiviral; PCD; polyanionic carbosilane dendrimer; MSM; men who have sex with men; SVR; sustained virological response; HIV; human i
Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells
Keywords: پاسخ ویروسی بالقوه; IFN-λ; Hepatitis C virus; Autophagy; ATG5; GABARAP; IFN-λ; interferon-λ; HCV; hepatitis C virus; LC3B; microtubule-associated protein 1 light chain 3B; HCC; hepatocellular carcinoma; DAAs; directly acting antivirals; SVR; sustained virological response
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
Keywords: پاسخ ویروسی بالقوه; Antiviral agents; Direct-acting antivirals; Polymerase inhibitor; NS5A inhibitor; EC50; half-maximal effective concentration; HCV; hepatitis C virus; LLOQ; lower limit of quantification; RASs; resistance-associated substitutions; SVR; sustained virologica
Polymorphisms of chemokine receptor genes and clearance of hepatitis C virus infection in Chinese population
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; PEG; pegylated; RBV; ribavirin; SNPs; single nucleotide polymorphisms; SVR; sustained virological response; HWE; Hardy-Weinberg equilibrium; ALT; alanine aminotransferase; AST; aspartate aminotransferase; AFP; alpha fetal protein;
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Keywords: پاسخ ویروسی بالقوه; Liver Cancer; Outcome; Viral Hepatitis; Therapy; AUDIT-C; Alcohol Use Disorders Identification Test; CCR; Central Cancer Registry; CDW; Corporate Data Warehouse; CI; confidence interval; DAA; direct acting antivirals; HCC; hepatocellular cancer; HCV; hepa
Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s
Keywords: پاسخ ویروسی بالقوه; Hepatitis C infection; Anti-D; Disease outcomes; Cirrhosis; Competing risks regression; Cohort study; Genotype 1b; Chronic infection; Sustained virological response;
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Keywords: پاسخ ویروسی بالقوه; Antiviral Therapy; Direct-acting Antivirals; Liver Disease; Portal Hypertension; AUROC; areas under the receiver operating characteristic curve; CPT; Child-Pugh Turcotte; CPT-B; Child-Pugh Turcotte-stage B; CSPH; clinically significant portal hypertension
Vitamin D and K signaling pathways in hepatocellular carcinoma
Keywords: پاسخ ویروسی بالقوه; (1,25(OH)2D3); 1,25-dihydroxycholecalciferol; (7-DHC); 7-dehydrocholesterol; (BCLC); Barcelona-Clınic Liver Cancer; (EPIC); The European Prospective Investigation into Cancer and Nutrition; (GGCX); gamma-glutamyl carboxylase; (HCC); hepatocellular carcin
Research ArticleBoceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients
Keywords: پاسخ ویروسی بالقوه; MSM; men having sex with men; HCV; hepatitis C virus; AHCV; acute hepatitis C virus; PegIFN; pegylated interferon; SVR; sustained virological response; RBV; ribavirin; DAA; direct-acting antiviral; DAHHS; Dutch Acute HCV in HIV Study; cART; combination an
Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin
Keywords: پاسخ ویروسی بالقوه; Abbott RealTime hepatitis C virus assay; Hepatitis C virus; Rapid virological response; Sustained virological response
Liver, Pancreas and Biliary TractDual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
Keywords: پاسخ ویروسی بالقوه; Cirrhosis; Hepatitis C virus; IL28B polymorphisms; Iron liver overload; Peg-interferon; Ribavirin; Sustained virological response; Thalassemia major;
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; IFN; interferon; LD; linkage disequilibrium; LD; linkage disequilibrium; NR; no responder; PEG-IFN/RBV; pegylated interferon-alpha plus ribavirin; SVC; spontaneous viral clearance; SVR; sustained virological response; HCV; CD209; I
Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C
Keywords: پاسخ ویروسی بالقوه; Asia; hepatitis C; interferon; sustained virological response; vitamin D receptor
Research ArticleHepatitis C reinfection after sustained virological response
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; PWID; people who inject drugs; SVR; sustained virological response; IDU; injecting drug use; DAAs; direct-acting antivirals; RNA; ribonucleic acid; OST; opioid substitution treatment; RVR; rapid virological response; E1; envelope 1
Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis
Keywords: پاسخ ویروسی بالقوه; Interferon-lambda 4; Hepatitis C virus; Interleukin 28b; Sustained virological response; Meta-analysis;
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; DAA; direct-acting antiviral; MELD; model for end-stage liver disease; SVR; sustained virological response; EAP; expanded access programme; HCVRUK; hepatitis C Research UK; SOF; sofosbuvir; LDV; ledipasvir; DCV; daclatasvir; RBV; r
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Keywords: پاسخ ویروسی بالقوه; HCC; hepatocellular carcinoma; DAA; direct-acting antivirals; HCV; hepatitis C virus; SVR; sustained virological response; AIFA; Italian Medicines Agency; CEUS; contrast-enhanced ultrasonography; CT; computerized tomography; MRI; magnetic resonance imagin
Research ArticleHCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir
Keywords: پاسخ ویروسی بالقوه; HCV; hepatitis C virus; DAAs; direct-acting antiviral agents; SVR; sustained virological response; HCV; Viral kinetics; Mathematical modeling; SVR; Duration of therapy;
Research ArticleImpact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
Keywords: پاسخ ویروسی بالقوه; DAA; direct acting antiviral; HCV; hepatitis C virus; EAP; Expanded access programme; SVR; sustained virological response; MELD; model for end-stage liver disease; ALT; alanine aminotransferase; RNA; ribonucleic acid; HIV; human immunodeficiency virus; SA
Heterogeneous genomic locations within NS3, NS4A and NS4B identified for genotyping and subtyping of Hepatitis C virus: A simple genome analysis approach
Keywords: پاسخ ویروسی بالقوه; bs; bootstrap; GTR; general time reversible; HCV; Hepatitis C virus; MCL; maximum composite likelihood; ML; maximum likelihood; N-J; neighbor-joining; RA; reference alignment; SVR; sustained virological response; HCV; Genotyping; Subtyping; Phylogenetic a
Research ArticleClinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens
Keywords: پاسخ ویروسی بالقوه; SOF; sofosbuvir; CAP/CTM; COBAS AmpliPrep/COBAS TaqMan v2.0; ART; Abbott RealTime HCV test; GT; genotype; RBV; ribavirin; PegIFN; pegylated-interferon alfa; SMV; simeprevir; HCV; hepatitis C virus; SVR; sustained virological response; DAA; direct-acting a
Management of the patient with SVR
Keywords: پاسخ ویروسی بالقوه; Sustained virological response; Fibrosis regression; Liver-related mortality; Prevention